Kratom alkaloids

Kratom alkaloids are a diverse group of over 40 bioactive compounds derived from the leaves of the Mitragyna speciosa tree, a plant native to Southeast Asia (StatPearls, 2023). The primary alkaloids, mitragynine and 7-hydroxymitragynine, are known for their complex pharmacology involving the opioid system, where they act as G-protein biased partial agonists at the mu-opioid receptor (Kruegel et al., 2016). This biased signaling is of significant therapeutic interest because it may provide analgesia with a lower risk of life-threatening respiratory depression compared to traditional opioids (NCCIH, 2023). Beyond opioid receptors, these alkaloids also modulate adrenergic, serotonergic, and dopaminergic pathways, contributing to their dose-dependent effects which range from stimulation at low doses to analgesia and sedation at higher doses (Eastlack et al., 2020). While traditionally used for fatigue and pain, they are currently being researched for their potential in treating opioid withdrawal and chronic pain (PubMed, 2021). However, safety concerns persist regarding their potential for addiction, liver toxicity, and significant drug-drug interactions mediated by the inhibition of various cytochrome P450 enzymes (FDA, 2022).

Other names

Mitragyna speciosa alkaloidsMitragynine and related compoundsKratom leaf alkaloids

Partial agonism of the mu-opioid receptor; Antagonism of kappa- and delta-opioid receptors; G-protein biased signaling; Alpha-2 adrenergic receptor agonism; 5-HT2A receptor antagonism.